Notably, a tumor-suppressive effect of TSLP-TSLPR signaling recently has been demonstrated in mouse models of skin cancer by promoting a T cell-mediated antitumor response and inhibiting skin accumulation of immunosuppressive Gr-1+ myeloid cells [38, 39]. The gene discussed is CRLF2; the disease is skin cancer.